Unknown

Dataset Information

Review of the COVID-19 Risk in Multiple Sclerosis.


ABSTRACT: The ongoing pandemic of the novel coronavirus of 2019 (COVID-19) has resulted in over 1 million deaths, primarily affecting older patients with chronic ailments. Multiple sclerosis (MS) patients have been deemed particularly vulnerable given their high rates of disability and increased susceptibility to infections. There have also been concerns regarding disease-modifying therapy (DMT) during the pandemic as many DMTs may increase the risk of infection due to some of their immunosuppressive properties. Furthermore, due to MS-related chronic inflammatory damage within the central nervous system, there have been concerns for worsening neurological injury by COVID-19. This has resulted in an alarmingly high level of anxiety and stress among the MS community leading to a lack of compliance wit

SUBMITTER: Chaudhry F 

PROVIDER: S-EPMC8098748 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature